Ascend Wellness Holdings (AAWH) delivered a Q1 2025 revenue print of $128.0 million with an adjusted EBITDA margin of 21.1%, underscoring management’s focus on cost discipline and a margin re-rating in a price-compressed cannabis environment. Year-over-year and quarter-over-quarter metrics show a demand environment still resilient to regulatory headwinds, but top-line pressures remain driven by ongoing price compression and a heavier wholesale mix. Management reaffirmed a growth-oriented densification plan, with 50% store expansion in core markets over the next 18 months and a near-term push to 10 new doors in 2025, bolstered by a broader CPG and e-commerce program that is beginning to gain traction. The company also advanced its capital allocation strategy via a buyback program (approximately 1.57 million shares repurchased by end-April) and signaled continued investment in automation, product launches, and M&A opportunities that could unlock further margin expansion and revenue growth. On the liquidity front, Ascend closed the quarter with $100 million in cash, reflecting continued operating cash flow generation and favorable financing activity, though the balance sheet remains leveraged, with total debt and negative equity characteristics consistent with the cannabis sector’s capital structure. In summary, AAWH is pursuing a multiyear value-creation agenda centered on retail densification, vertical integration, and a strengthened customer-centric framework, while navigating persistent price compression and market competition.